Showing results (261-270 of 464) with videos related to
Sort By:
Pageof 47
American Journal of Clinical Oncology|December 10, 2020
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing RegimensEric I Marks, Robert Matera, Adam J Olszewski, et al.Oncotarget|October 6, 2021
Pan-drug and drug-specific mechanisms of 5-FU, irinotecan (CPT-11), oxaliplatin, and cisplatin identified by comparison of transcriptomic and cytokine responses of colorectal cancer cellsLindsey Carlsen, Christoph Schorl, Kelsey Huntington, et al.Oncology Letters|June 17, 2014
Detection of circulating tumor cells in the cerebrospinal fluid of a patient with a solitary metastasis from breast cancer: A case reportAkshal S Patel, Joshua E Allen, David T Dicker, et al.American Journal of Cancer Research|January 8, 2024
ONC201/TIC10 plus TLY012 anti-cancer effects via apoptosis inhibitor downregulation, stimulation of integrated stress response and death receptor DR5 in gastric adenocarcinomaCassandra S Parker, Lanlan Zhou, Varun V Prabhu, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|September 28, 2000
Aberrant regulation and function of wild-type p53 in radioresistant melanoma cellsK Satyamoorthy, N H Chehab, M J Waterman, et al.Cancer Research|December 5, 2000
Bax is a transcriptional target and mediator of c-myc-induced apoptosisK O Mitchell, M S Ricci, T Miyashita, et al.International Journal of Oncology|May 4, 2011
FLT-PET may not be a reliable indicator of therapeutic response in p53-null malignancySharyn I Katz, Lanlan Zhou, Thomas A Ferrara, et al.Cell Cycle (Georgetown, Tex.)|July 2, 2011
Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumabLori S Hart, Nathan G Dolloff, David T Dicker, et al.Cancer Biology & Therapy|November 20, 2009
The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cellsCatherine Huang, Xiang M Zhang, Raluca T Tavaluc, et al.Cancer Research|October 25, 2017
miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer CellsAmriti R Lulla, Michael J Slifker, Yan Zhou, et al.Pageof 47